Viewing Study NCT01591850


Ignite Creation Date: 2025-12-24 @ 5:23 PM
Ignite Modification Date: 2025-12-28 @ 12:37 PM
Study NCT ID: NCT01591850
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2012-05-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module